Novel role of NOD2 in mediating Ca2+ signaling: Evidence from NOD2-regulated podocyte TRPC6 channels in hyperhomocysteinemia

Hypertension

Volumn 62, Issue 3, 2013, Pages 506-511

  Han, Huirong ^a,b   Wang, Yupeng ^a   Li, Xiang ^a   Wang, Ping An ^a   Wei, Xinbing ^a   Liang, Wei ^c   Ding, Guohua ^c   Yu, Xiao ^a   Bao, Chanchan ^a   Zhang, Yan ^a   Wang, Ziying ^a   Yi, Fan ^a  

^a SHANDONG UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

calcium signaling; homocysteine; NLR family; transient receptor potential channel

Indexed keywords

CALCIUM ION; CASPASE RECRUITMENT DOMAIN PROTEIN 15; HOMOCYSTEINE; NEPHRIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; GENE OVEREXPRESSION; GLOMERULOSCLEROSIS; HYPERHOMOCYSTEINEMIA; INNATE IMMUNITY; KIDNEY INJURY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CALCIUM SIGNALING; HOMOCYSTEINE; NLR FAMILY; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ANIMALS; CALCIUM SIGNALING; CYTOSKELETON; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; PODOCYTES; TRPC CATION CHANNELS;

EID: 84883298849     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01638     Document Type: Article

References (28)

1. Yi F, Li PL. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol. 2008;28:254-264.
2. Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, Vigo P, Mayer EL, Selhub J, Kutner M, Jacobsen DW. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 1996;94:2743-2748.
3. Yi F, Xia M, Li N, Zhang C, Tang L, Li PL. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension. 2009;53:90-96.
4. Yi F, dos Santos EA, Xia M, Chen QZ, Li PL, Li N. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol. 2007;27:262-268.
5. Yi F, Zhang AY, Li N, Muh RW, Fillet M, Renert AF, Li PL. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006;70:88-96.
6. Zhang C, Boini KM, Xia M, Abais JM, Li X, Liu Q, Li PL. Activation of Nodlike receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60:154-162.
7. Spence JD, Stampfer MJ. Understanding the complexity of homocysteine lowering with vitamins: The potential role of subgroup analyses. JAMA. 2011;306:2610-2611.
8. Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123:1763-1770.
9. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7:1250-1257.
10. Lech M, Avila-Ferrufino A, Skuginna V, Susanti HE, Anders HJ. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasomerelated mRNAs in humans and mice. Int Immunol. 2010;22:717-728.
11. Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB. Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol. 2010;184:2297-2304.
12. Du P, Fan B, Han H, Zhen J, Shang J, Wang X, Li X, Shi W, Tang W, Bao C, Wang Z, Zhang Y, Zhang B, Wei X, Yi F. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int. 2013;In Press.
13. Shastry S, James LR. Homocysteine-induced macrophage inflammatory protein-2 production by glomerular mesangial cells is mediated by PI3 Kinase and p38 MAPK. J Inflamm (Lond). 2009;6:27.
14. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007;9:1941-1958.
15. Mathieson PW. The podocyte as a target for therapies-new and old. Nat Rev Nephrol. 2012;8:52-56.
16. Thilo F, Liu Y, Loddenkemper C, Schuelein R, Schmidt A, Yan Z, Zhu Z, Zakrzewicz A, Gollasch M, Tepel M. VEGF regulates TRPC6 channels in podocytes. Nephrol Dial Transplant. 2012;27:921-929.
17. Yi F, Jin S, Zhang F, Xia M, Bao JX, Hu J, Poklis JL, Li PL. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: An early event of homocysteine-induced glomerular injury. J Cell Mol Med. 2009;13:3303-3314.
18. Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH. Nodlike proteins in inflammation and disease. J Pathol. 2008;214:136-148.
19. Ting JP, Duncan JA, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science. 2010;327:286-290.
20. Fornoni A. Proteinuria, the podocyte, and insulin resistance. N Engl J Med. 2010;363:2068-2069.
21. Eckel J, Lavin PJ, Finch EA, et al. TRPC6 enhances angiotensin II-induced albuminuria. J Am Soc Nephrol. 2011;22:526-535.
22. Dryer SE, Reiser J. TRPC6 channels and their binding partners in podocytes: Role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol. 2010;299:F689-F701.
23. Reiser J, Polu KR, Möller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005;37:739-744.
24. Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi PG, Reponen P, Tryggvason K, Camussi G. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol. 2001;158:1723-1731.
25. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroidresistant nephrotic syndrome. J Am Soc Nephrol. 2002;13:388-393.
26. Welsh GI, Saleem MA. Nephrin-signature molecule of the glomerular podocyté J Pathol. 2010;220:328-337.
27. Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, Obukhov AG, Vogel SM, Schraufnagel DE, Dietrich A, Birnbaumer L, Malik AB, Mehta D. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med. 2012;209:1953-1968.
28. Thilo F, Scholze A, Liu DY, Zidek W, Tepel M. Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines. Arch Biochem Biophys. 2008;471:57-62.